What are the recommended medications for a patient with a history of motion sickness to prevent sea sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sea Sickness Medication

Scopolamine transdermal patch is the first-line medication for preventing sea sickness, applied 4-16 hours before anticipated motion exposure, with a 75% reduction in motion-induced nausea and vomiting. 1

Primary Recommendation: Scopolamine Transdermal System

  • Apply the scopolamine transdermal patch (1 mg/3 days) to the hairless area behind one ear at least 4 hours before departure, ideally 4-16 hours prior to motion exposure. 1
  • The patch delivers approximately 1 mg of scopolamine over 3 days, with peak plasma concentrations reached within 24 hours and detectable levels within 4 hours of application. 1
  • Clinical efficacy studies demonstrated a 75% reduction in motion-induced nausea and vomiting in 195 adult subjects exposed to motion at sea or in controlled motion environments. 1
  • The patch can remain in place for up to 3 days of continuous protection. 1

Alternative: First-Generation Antihistamines

  • First-generation antihistamines (such as dimenhydrinate or meclizine) are effective alternatives, though they cause sedation. 2
  • Dimenhydrinate showed statistical superiority over placebo (p = 0.05) in preventing motion sickness at sea, though it was less effective than transdermal scopolamine (p = 0.0001). 3
  • Antihistamines must be taken before departure to be effective in everyday motion sickness situations, but their overall effectiveness is limited compared to scopolamine. 4

Administration Details and Timing

  • For scopolamine patch: Apply 4-16 hours before anticipated motion exposure; wash hands thoroughly with soap and water immediately after application. 1
  • Use only one transdermal system at a time; do not cut the patch. 1
  • If the patch becomes displaced, discard it and apply a new patch behind the other ear. 1
  • Upon removal after 3 days, fold the used patch in half with sticky sides together and discard in household trash to prevent accidental contact. 1

Important Safety Considerations and Side Effects

  • Common side effects of scopolamine include dry mouth, drowsiness, and blurred vision, though these are typically minimal with the transdermal formulation. 3
  • Scopolamine acts centrally by blocking cholinergic transmission from the vestibular nuclei to higher CNS centers and can cause pupil dilation, increased heart rate, and decreased gastrointestinal motility. 1
  • Avoid touching the patch during treatment, as pressure may cause scopolamine to ooze out at the edges. 1
  • Wash hands and application site thoroughly with soap and water after patch removal. 1

What Does NOT Work

  • Nonsedating antihistamines, ondansetron, and ginger root are NOT effective for prevention or treatment of motion sickness. 2

Behavioral Strategies to Combine with Medication

  • Position yourself in the most stable part of the vessel (typically midship and on deck). 2
  • Watch the true visual horizon rather than focusing on objects inside the vessel. 2
  • Lie down with eyes closed if possible. 2
  • Minimize other sources of physical, mental, and emotional discomfort. 2

Special Populations

  • Children aged 2-12 years are most susceptible to motion sickness. 5
  • Women are more susceptible than men, with increased risk during menstruation and pregnancy. 5
  • Symptoms typically last no longer than 3 days in otherwise healthy individuals. 5

References

Research

Prevention and treatment of motion sickness.

American family physician, 2014

Research

Transdermal scopolamine in the prevention of motion sickness at sea.

Clinical pharmacology and therapeutics, 1981

Research

[Motion sickness in motion: from carsickness to cybersickness].

Nederlands tijdschrift voor geneeskunde, 2018

Research

[Motion sickness at sea and in the air].

Duodecim; laaketieteellinen aikakauskirja, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.